{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:07:21Z","timestamp":1790356041189,"version":"4.1.0"},"reference-count":116,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070213"],"award-info":[{"award-number":["82070213"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370196"],"award-info":[{"award-number":["82370196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["82070213"],"award-info":[{"award-number":["82070213"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"award":["82370196"],"award-info":[{"award-number":["82370196"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Cytomegalovirus retinitis (CMVR) causes irreversible visual loss in patients with severe cellular immunodeficiency. Among people living with human immunodeficiency virus (HIV), risk is the highest with profound CD4+ T-cell depletion and absent or ineffective antiretroviral therapy. Other susceptible groups include transplant recipients, patients receiving treatment for malignancy or targeted immunosuppression, and children with inborn errors of immunity. This narrative review connects risk assessment, diagnosis, antiviral selection, and follow-up. Dilated retinal examination and serial imaging establish lesion activity and vision threat. Ocular-fluid polymerase chain reaction supports uncertain diagnoses, but results require interpretation alongside retinal findings and prior treatment. Antiviral selection requires concurrent assessment of lesion location, diagnostic certainty, renal function, marrow reserve, and systemic cytomegalovirus (CMV) disease. Systemic valganciclovir or ganciclovir provides the treatment backbone when feasible; immediately sight-threatening lesions may require adjunctive intravitreal therapy. Resistance or toxicity can necessitate alternatives, while evidence for newer agents remains limited. Maintenance duration depends on retinal inactivity and sustained immune recovery, with less certain stopping criteria outside HIV. Surveillance should address recurrence, immune recovery uveitis, retinal detachment, macular and vascular injury, and visual dysfunction beyond central acuity. Geographically diverse studies illustrate detection gaps, although heterogeneous populations and methods limit direct comparisons of burden and treatment outcomes.<\/jats:p>","DOI":"10.3390\/jcm15197482","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:31:14Z","timestamp":1790353874000},"page":"7482","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cytomegalovirus Retinitis Across the Immunosuppression Spectrum: A Contemporary Framework for Risk Stratification, Diagnosis, and Vision-Preserving Therapy"],"prefix":"10.3390","volume":"15","author":[{"given":"Shuai","family":"Su","sequence":"first","affiliation":[{"name":"Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6976-6521","authenticated-orcid":false,"given":"Yulin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7274-6774","authenticated-orcid":false,"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Zhang, J., Kamoi, K., Zong, Y., Yang, M., Zou, Y., Miyagaki, M., and Ohno-Matsui, K. (2024). Cytomegalovirus Retinitis: Clinical Manifestations, Diagnosis and Treatment. Viruses, 16.","DOI":"10.3390\/v16091427"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Munro, M., Yadavalli, T., Fonteh, C., Arfeen, S., and Lobo-Chan, A.M. (2020). Cytomegalovirus Retinitis in HIV and Non-HIV Individuals. Microorganisms, 8.","DOI":"10.3390\/microorganisms8010055"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.ophtha.2010.03.031","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: Five-year outcomes","volume":"117","author":"Jabs","year":"2010","journal-title":"Ophthalmology"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ude, I.N., Yeh, S., and Shantha, J.G. (2022). Cytomegalovirus retinitis in the highly active anti-retroviral therapy era. Ann. Eye Sci., 7.","DOI":"10.21037\/aes-21-18"},{"key":"ref_5","unstructured":"Standardization of Uveitis Nomenclature (SUN) Working Group (2021). Classification Criteria for Cytomegalovirus Retinitis. Am. J. Ophthalmol., 228, 245\u2013254."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Baethge, C., Goldbeck-Wood, S., and Mertens, S. (2019). SANRA-a scale for the quality assessment of narrative review articles. Res. Integr. Peer Rev., 4.","DOI":"10.1186\/s41073-019-0064-8"},{"key":"ref_7","unstructured":"(2026, September 19). Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Cytomegalovirus Disease. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Updated 14 July 2025; Reviewed 16 March 2026, Available online: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections\/cytomegalovirus."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TP.0000000000005374","article-title":"The Fourth International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation","volume":"109","author":"Kotton","year":"2025","journal-title":"Transplantation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa011759","article-title":"A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis","volume":"346","author":"Martin","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ajo.2011.11.014","article-title":"Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"153","author":"Sugar","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ajo.2011.10.012","article-title":"Clinical features of newly diagnosed cytomegalovirus retinitis in northern Thailand","volume":"153","author":"Ausayakhun","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Passarin, O., Hoogewoud, F., Manuel, O., and Guex-Crosier, Y. (2024). Clinical manifestations and immune markers of non-HIV-related CMV retinitis. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-09653-x"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Ocieczek, P., Barnacle, J.R., Gumulira, J., Phiri, S., Heller, T., and Grabska-Liberek, I. (2019). Cytomegalovirus Retinitis Screening and Treatment in Human Immunodeficiency Virus Patients in Malawi: A Feasibility Study. Open Forum Infect. Dis., 6.","DOI":"10.1093\/ofid\/ofz439"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ei, W.L.S.S., Pyar Soe, K., Hilbig, A., Murray, J., and Heiden, D. (2019). Routine Immediate Eye Examination at the Point of Care for Diagnosis of AIDS-Related Cytomegalovirus Retinitis Among Patients with a CD4 Count <100 in Myanmar. Open Forum Infect. Dis., 6.","DOI":"10.1093\/ofid\/ofz280"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/QAI.0000000000003885","article-title":"Brief Report: Clinical Features of Newly Diagnosed Cytomegalovirus Retinitis in South India","volume":"101","author":"Rathinam","year":"2026","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/09564624221135294","article-title":"Cytomegalovirus retinitis in hospitalized people living with HIV in the late antiretroviral therapy era in S\u00e3o Paulo, Brazil","volume":"34","author":"Bogoni","year":"2023","journal-title":"Int. J. STD AIDS"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.ophtha.2012.03.032","article-title":"Risk factors for cytomegalovirus retinitis in patients with cytomegalovirus viremia after hematopoietic stem cell transplantation","volume":"119","author":"Jeon","year":"2012","journal-title":"Ophthalmology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/s41409-020-01176-8","article-title":"Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening","volume":"56","author":"Mori","year":"2021","journal-title":"Bone Marrow Transpl."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zeng, Q., Yao, Y., Hou, J., and Miao, H. (2025). Clinical Characteristics and Prognostic Factors Affecting Clinical Outcomes in Cytomegalovirus Retinitis Following Allogeneic Hematopoietic Stem Cell Transplantation. Biomedicines, 13.","DOI":"10.3390\/biomedicines13010242"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/09273948.2024.2406310","article-title":"Risk Factors of Cytomegalovirus Retinitis Occurrence After Allogeneic Hematopoietic Stem Cell Transplantation","volume":"33","author":"Zhang","year":"2025","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Bharaj, D.K., Dhanji, S., Gurung, E., Ladua, G., Lowe, C.F., Matic, N., Gill, J., Mah, A., Wright, A.J., and Ta Kim, D. (2026). Diabetes Mellitus is a Risk Factor for Developing CMV Retinitis in Solid Organ Transplant Recipients: A Case-control Study. Open Forum Infect. Dis., 13.","DOI":"10.1093\/ofid\/ofag056"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1399-3062.2007.00241.x","article-title":"Clinical features and outcomes of cytomegalovirus retinitis after transplantation","volume":"10","author":"Eid","year":"2008","journal-title":"Transpl. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1093\/cid\/ciad474","article-title":"Unintended Consequences: Risk of Opportunistic Infections Associated with Long-term Glucocorticoid Therapies in Adults","volume":"78","author":"Chastain","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/j.ijid.2010.03.025","article-title":"Does rituximab increase the incidence of infectious complications? A narrative review","volume":"15","author":"Kelesidis","year":"2011","journal-title":"Int. J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.anai.2023.01.018","article-title":"Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab","volume":"130","author":"Athni","year":"2023","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1093\/rheumatology\/kez681","article-title":"Tofacitinib-associated cytomegalovirus retinitis","volume":"59","author":"Cugley","year":"2020","journal-title":"Rheumatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jiac.2017.03.002","article-title":"Cytomegalovirus retinitis followed by immune recovery uveitis in an elderly patient with rheumatoid arthritis undergoing administration of methotrexate and tofacitinib combination therapy","volume":"23","author":"Yanagisawa","year":"2017","journal-title":"J. Infect. Chemother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4078\/jrd.2025.0019","article-title":"Cytomegalovirus retinitis during upadacitinib monotherapy for rheumatoid arthritis: A case report","volume":"33","author":"Park","year":"2026","journal-title":"J. Rheum. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Johnson, C.D., El Zein, L., and Yamanuha, J. (2026). From infection to infarction: Cytomegalovirus retinitis complicated by retinal ischemia and vitreous hemorrhage in the setting of JAK inhibition\u2014A case report. BMC Ophthalmol., 26.","DOI":"10.1186\/s12886-025-04558-y"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/CM9.0000000000000065","article-title":"CD4+ cells as a potential biomarker for cytomegalovirus retinitis in children with acute lymphocytic leukemia","volume":"132","author":"Wang","year":"2019","journal-title":"Chin. Med. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1442-200X.2011.03429.x","article-title":"Retinitis from cytomegalovirus during maintenance treatment for acute lymphoblastic leukemia","volume":"54","author":"Kobayashi","year":"2012","journal-title":"Pediatr. Int."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0002-9394(99)00031-8","article-title":"Cytomegalovirus retinitis in immunosuppressed children","volume":"127","author":"Baumal","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/09273948.2021.1995762","article-title":"CMV Retinitis in Wiskott Aldrich Syndrome","volume":"31","author":"Luo","year":"2023","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ngai, J.J., Chong, K.L., and Oli Mohamed, S. (2018). Cytomegalovirus Retinitis in Primary Immune Deficiency Disease. Case Rep. Ophthalmol. Med., 2018.","DOI":"10.1155\/2018\/8125806"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lind, K.T., DeSmith, K., Marks, B., Deb, A., Dexiang, G., Mehner, L.C., and Eissa, H. (2025). Seeing the Bigger Picture: Cytomegalovirus Retinitis Screening in Pediatric Hematopoietic Stem Cell Transplant Patients. Pediatr. Blood Cancer, 72.","DOI":"10.1002\/pbc.31910"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Phasuk, N., Keatkla, J., Rattanasiri, S., Techasaensiri, C., Anurathapan, U., and Apiwattanakul, N. (2019). Monitoring of cytomegalovirus infection in non-transplant pediatric acute lymphoblastic leukemia patients during chemotherapy. Medicine, 98.","DOI":"10.1097\/MD.0000000000014256"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.ophtha.2004.05.028","article-title":"Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment","volume":"111","author":"Jabs","year":"2004","journal-title":"Ophthalmology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ajo.2016.03.015","article-title":"Long-term Follow-up of Cytomegalovirus Retinitis in Non-HIV Immunocompromised Patients: Clinical Features and Visual Prognosis","volume":"165","author":"Iu","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s00417-024-06415-y","article-title":"Immune recovery uveitis: A focus review","volume":"262","author":"Mota","year":"2024","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_41","first-page":"393","article-title":"Retinal detachment and mortality in patients with cytomegalovirus retinitis: A multicenter study in Taiwan","volume":"263","author":"Wu","year":"2025","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-109-12-963","article-title":"The diagnosis of cytomegalovirus retinitis","volume":"109","author":"Bloom","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"AlZaid, A., Khan, A., Al-Dhibi, H., and Magliyah, M.S. (2026). CMV retinitis: The diagnostic challenges and long-term outcomes. The experience of tertiary eye center in Saudi Arabia. J. Ophthalmic. Inflamm. Infect., 16.","DOI":"10.1186\/s12348-026-00572-3"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Leal, I., Agarwal, A., Berkenstock, M., Sonoda, K.H., Dodds, E., Kempen, J.H., Br\u00e9zin, A.P., Hwang, D.K., Cicinelli, M.V., and Invernizzi, A. (2026). Evidence and Consensus-Based Imaging Guidelines in Cytomegalovirus Retinitis: Multimodal Imaging in Uveitis (MUV) Task Force\u2014Report 15. Ophthalmol. Retin., advance online publication.","DOI":"10.1016\/j.oret.2026.05.004"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Wongchaisuwat, N., Khongpipatchaisiri, S., Boonsopon, S., Choopong, P., Tesavibul, N., Prakhunhungsit, S., Thoongsuwan, S., Rodanant, N., and Phasukkijwatana, N. (2020). Extralesional microvascular and structural macular abnormalities in cytomegalovirus retinitis. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-78587-6"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajo.2008.07.043","article-title":"Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis","volume":"147","author":"Harper","year":"2009","journal-title":"Am. J. Ophthalmol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/1120672119841777","article-title":"Polymerase chain reaction analysis of aqueous humor specimens in the diagnosis of cytomegalovirus retinitis in AIDS patients","volume":"30","author":"Mao","year":"2020","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1086\/339603","article-title":"Comparison of cytomegalovirus (CMV) UL97 gene sequences in the blood and vitreous of patients with acquired immunodeficiency syndrome and CMV retinitis","volume":"185","author":"Hu","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1080\/09273948.2021.1905857","article-title":"High Blood Cytomegalovirus Load Suggests Cytomegalovirus Retinitis in HIV\/AIDS Patients: A Cross-Sectional Study","volume":"30","author":"Du","year":"2022","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(04)16500-8","article-title":"Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy","volume":"363","author":"Deayton","year":"2004","journal-title":"Lancet"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00002030-199907090-00008","article-title":"Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy","volume":"13","author":"Deayton","year":"1999","journal-title":"AIDS"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ajo.2025.04.039","article-title":"Utility of Screening Examination for Cytomegalovirus Retinitis Among Patients with Cytomegalovirus Viremia","volume":"277","author":"Li","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00417-020-05011-0","article-title":"Development of cytomegalovirus retinitis after negative conversion of cytomegalovirus antigenemia due to systemic antiviral therapy","volume":"259","author":"Suzuki","year":"2021","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Jeong, S., Jeong, A., Do, J.R., Kang, Y.K., and Sagong, M. (2026). Efficacy of high-dose vs. low-dose intravitreal ganciclovir for cytomegalovirus retinitis: A systematic review and meta-analysis. J. Yeungnam Med. Sci., 43.","DOI":"10.12701\/jyms.2026.43.13"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2016.12.003","article-title":"Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene","volume":"138","author":"Chou","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Studies of Ocular Complications of AIDS Research Group, and AIDS Clinical Trials Group (1997). Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: The HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Ann. Intern. Med., 126, 264\u2013274.","DOI":"10.7326\/0003-4819-126-4-199702150-00002"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9394(01)00840-6","article-title":"The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial","volume":"131","author":"Jabs","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/09273948.2019.1662062","article-title":"Letermovir for the Management of Cytomegalovirus-associated Uveitis","volume":"29","author":"Tsui","year":"2021","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/cid\/ciab988","article-title":"Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial","volume":"75","author":"Avery","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Shughoury, A., Emami, S., Kaisari, E., Kharouba, R., Thomas, A.S., Goldstein, D.A., and Janetos, T.M. (2026). Maribavir for cytomegalovirus retinitis: A case series and review of the literature. AJO Int., 3.","DOI":"10.1016\/j.ajoint.2026.100247"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Tabatabaei, S.A., Mirzaei, A., Daneshvar, K., Ghochani, G., Mohammadi, N., Bahar, M.M., Mahdizad, Z., Esmaeili, K., Aminizade, M., and Karimi, M. (2026). Cytomegalovirus retinitis in diverse immunocompromised populations: Clinical presentation, treatment outcomes, and prognostic factors. Ther. Adv. Ophthalmol., 18.","DOI":"10.1177\/25158414261440308"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Heiden, D., Ford, N., Wilson, D., Rodriguez, W.R., Margolis, T., Janssens, B., Bedelu, M., Tun, N., Goemaere, E., and Saranchuk, P. (2007). Cytomegalovirus retinitis: The neglected disease of the AIDS pandemic. PLoS Med., 4.","DOI":"10.1371\/journal.pmed.0040334"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Heiden, D., and Saranchuk, P. (2011). CMV retinitis in China and SE Asia: The way forward. BMC Infect. Dis., 11.","DOI":"10.1186\/1471-2334-11-327"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ophtha.2006.03.021","article-title":"Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"113","author":"Thorne","year":"2006","journal-title":"Ophthalmology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajo.2014.10.014","article-title":"Retinal detachment associated with AIDS-related cytomegalovirus retinitis: Risk factors in a resource-limited setting","volume":"159","author":"Yen","year":"2015","journal-title":"Am. J. Ophthalmol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/OPTH.S6700","article-title":"Optimal management of cytomegalovirus retinitis in patients with AIDS","volume":"4","author":"Stewart","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ophtha.2009.06.016","article-title":"Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS","volume":"117","author":"Jabs","year":"2010","journal-title":"Ophthalmology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajo.2007.09.040","article-title":"Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000)","volume":"145","author":"Holland","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1590\/S0004-27492010000100003","article-title":"Clinical features and outcomes of AIDS-related cytomegalovirus retinitis in the era of highly active antiretroviral therapy","volume":"73","author":"Arantes","year":"2010","journal-title":"Arq. Bras. Oftalmol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Tang, Y., Sun, J., He, T., Shen, Y., Liu, L., Steinhart, C.R., Chen, J., Qi, T., Wang, Z., and Song, W. (2020). Clinical Features of Cytomegalovirus Retinitis in HIV Infected Patients. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00136"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/09273948.2020.1772312","article-title":"Clinical Features and CD4+ T Cells Count in AIDS Patients with CMV Retinitis: Correlation with Mortality","volume":"30","author":"Agrawal","year":"2022","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajo.2004.04.015","article-title":"Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection","volume":"138","author":"Kuo","year":"2004","journal-title":"Am. J. Ophthalmol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/09273948.2019.1604003","article-title":"Presenting Features, Treatment and Clinical Outcomes of Cytomegalovirus Retinitis: Non-HIV Patients Vs HIV Patients","volume":"28","author":"Ho","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/IAE.0000000000001144","article-title":"Comparison of visual prognosis and clinical features of cytomegalovirus retinitis in HIV and non-HIV patients","volume":"37","author":"Kim","year":"2017","journal-title":"Retina"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/IAE.0000000000003631","article-title":"Clinical characteristics and prognostic factors affecting clinical outcomes in cytomegalovirus retinitis with or without HIV infection","volume":"43","author":"Su","year":"2023","journal-title":"Retina"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/jamaophthalmol.2013.2860","article-title":"Clinical manifestations of cytomegalovirus-associated posterior uveitis and panuveitis in patients without human immunodeficiency virus infection","volume":"131","author":"Pathanapitoon","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1097\/IAE.0b013e318285f486","article-title":"Chronic retinal necrosis: Cytomegalovirus necrotizing retinitis associated with panretinal vasculopathy in non-HIV patients","volume":"33","author":"Schneider","year":"2013","journal-title":"Retina"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Davis, J.L., Haft, P., and Hartley, K. (2013). Retinal arteriolar occlusions due to cytomegalovirus retinitis in elderly patients without HIV. J. Ophthalmic. Inflamm. Infect., 3.","DOI":"10.1186\/1869-5760-3-17"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Reddy, S., Tyagi, M., Behera, S., Pappuru, R.R., Dave, V.P., Basu, S., and Agrawal, H. (2021). Cytomegalovirus retinitis in patients of non-Hodgkin\u2019s lymphoma: Clinical presentations and outcomes. J. Ophthalmic. Inflamm. Infect., 11.","DOI":"10.1186\/s12348-021-00257-z"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00417-020-04871-w","article-title":"Clinical features of cytomegalovirus retinitis after solid organ transplantation versus hematopoietic stem cell transplantation","volume":"259","author":"Son","year":"2021","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Murray, J., Hilbig, A., Soe, T.T., Ei, W.L.S.S., Soe, K.P., and Ciglenecki, I. (2020). Treating HIV-associated cytomegalovirus retinitis with oral valganciclovir and intra-ocular ganciclovir by primary HIV clinicians in southern Myanmar: A retrospective analysis of routinely collected data. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05579-2"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09273948.2018.1538460","article-title":"Spectrum of Newly Diagnosed Cytomegalovirus Retinitis in a Developing Country in the HAART Era","volume":"28","author":"Singh","year":"2020","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Ismail, M.F., Khalafalla, I., Sheck, Z.O., Farah, F.A., Warsame, A.A., Mohamed, I.A., Mire, A.M., and Mumin, B.A. (2026). Prevalence and Risk Factors for Cytomegalovirus Retinitis Among People Living with HIV in Sub-Saharan Africa in the Antiretroviral Therapy Era: A Systematic Review and Meta-Analysis. Sci. Rep., 16.","DOI":"10.1038\/s41598-026-48848-x"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.4437","article-title":"The pathogenesis of human cytomegalovirus","volume":"235","author":"Griffiths","year":"2015","journal-title":"J. Pathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.cmi.2022.05.034","article-title":"Comparative clinical manifestations and immune effects of cytomegalovirus infections following distinct types of immunosuppression","volume":"28","author":"Ong","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Kobayashi, R., and Hashida, N. (2024). Overview of Cytomegalovirus Ocular Diseases: Retinitis, Corneal Endotheliitis, and Iridocyclitis. Viruses, 16.","DOI":"10.3390\/v16071110"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/319683","article-title":"Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis","volume":"183","author":"Komanduri","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/cid\/ciad575","article-title":"Immune Monitoring-Guided Versus Fixed Duration of Antiviral Prophylaxis Against Cytomegalovirus in Solid-Organ Transplant Recipients: A Multicenter, Randomized Clinical Trial","volume":"78","author":"Manuel","year":"2024","journal-title":"Clin. Infect. Dis."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1310\/hct1003-143","article-title":"Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: Results of ACTG protocol A5030","volume":"10","author":"Wohl","year":"2009","journal-title":"HIV Clin. Trials"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1080\/09273948.2025.2522955","article-title":"Comparison of Clinical Characteristics Among Herpetic Retinitis: Acute Retinal Necrosis and Cytomegalovirus Retinitis","volume":"33","author":"Hirai","year":"2025","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"478","DOI":"10.18240\/ijo.2025.03.15","article-title":"Investigation of the infection route of HIV-associated cytomegalovirus retinitis","volume":"18","author":"Cai","year":"2025","journal-title":"Int. J. Ophthalmol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0161-6420(92)31803-2","article-title":"Visual field testing in the management of cytomegalovirus retinitis","volume":"99","author":"Bachman","year":"1992","journal-title":"Ophthalmology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.ophtha.2015.02.033","article-title":"Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort","volume":"122","author":"Jabs","year":"2015","journal-title":"Ophthalmology"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","article-title":"ISCEV Standard for full-field clinical electroretinography (2022 update)","volume":"144","author":"Robson","year":"2022","journal-title":"Doc. Ophthalmol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10633-020-09812-w","article-title":"ISCEV standard for clinical multifocal electroretinography (mfERG) (2021 update)","volume":"142","author":"Hoffmann","year":"2021","journal-title":"Doc. Ophthalmol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10633-025-10042-1","article-title":"ISCEV standard for clinical visual evoked potentials (2025 update)","volume":"151","author":"Bach","year":"2025","journal-title":"Doc. Ophthalmol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.survophthal.2024.11.004","article-title":"Antiviral therapy for cytomegalovirus retinitis: A systematic review and meta-analysis","volume":"70","author":"Putera","year":"2025","journal-title":"Surv. Ophthalmol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJM199509073331002","article-title":"Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS","volume":"333","author":"Drew","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant","volume":"340","author":"Martin","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Studies of Ocular Complications of AIDS Research Group, and AIDS Clinical Trials Group (1992). Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N. Engl. J. Med., 326, 213\u2013220.","DOI":"10.1056\/NEJM199201233260401"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archopht.1994.01090240037023","article-title":"Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial","volume":"112","author":"Martin","year":"1994","journal-title":"Arch. Ophthalmol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199707103370203","article-title":"Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant","volume":"337","author":"Musch","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Choopong, P., Vivittaworn, K., Konlakij, D., Thoongsuwan, S., Pituksung, A., and Tesavibul, N. (2016). Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-1490-6"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Qian, Z., Li, H., Tao, Y., and Li, W. (2018). Initial intravitreal injection of high-dose ganciclovir for cytomegalovirus retinitis in HIV-negative patients. BMC Ophthalmol., 18.","DOI":"10.1186\/s12886-018-0983-z"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/s41433-022-02267-0","article-title":"Successful treatment of cytomegalovirus retinitis with oral\/intravitreal antivirals in HIV-negative patients with lymphoma","volume":"37","author":"Tasiopoulou","year":"2023","journal-title":"Eye"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/CMR.12.2.286","article-title":"Resistance of human cytomegalovirus to antiviral drugs","volume":"12","author":"Erice","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1086\/514041","article-title":"High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes","volume":"176","author":"Smith","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/512368","article-title":"Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis","volume":"44","author":"Martin","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.oret.2021.04.009","article-title":"Ocular Outcomes after Treatment of Cytomegalovirus Retinitis Using Adoptive Immunotherapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes","volume":"5","author":"Gupta","year":"2021","journal-title":"Ophthalmol. Retin."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1182\/bloodadvances.2019000121","article-title":"Adoptive T-cell therapy for pediatric cytomegalovirus-associated retinitis","volume":"3","author":"Seo","year":"2019","journal-title":"Blood Adv."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Hassman, L.M., Oo, K.T., Din, Z.M., Larochelle, M., Tun, N., Hobbs, R., Concepcion, C., Holland, G., Heiden, D., and Vitale, A.T. (2026). Argon laser demarcation of AIDS-related cytomegalovirus retinitis in resource-limited setting. Int. Ophthalmol., 46.","DOI":"10.1007\/s10792-025-03875-x"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00006982-199616020-00005","article-title":"Cytomegalovirus retinitis and optic neuritis in a child with severe combined immunodeficiency syndrome","volume":"16","author":"Perren","year":"1996","journal-title":"Retina"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ajo.2011.04.007","article-title":"Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis","volume":"152","author":"Holbrook","year":"2011","journal-title":"Am. J. Ophthalmol."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Yataka, S., Tsubota, K., Wakatsuki, K., Sugawara, R., Asakage, M., and Usui, Y. (2026). Cytomegalovirus Retinitis in Newly Diagnosed Advanced HIV Infection: A Three-Case Series Emphasizing Multidisciplinary Infection Screening. Infect. Dis. Rep., 18.","DOI":"10.3390\/idr18040066"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7482\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:34:56Z","timestamp":1790354096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/19\/7482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":116,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["jcm15197482"],"URL":"https:\/\/doi.org\/10.3390\/jcm15197482","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]}}}